molsidomine has been researched along with Age-Related Memory Disorders in 7 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a first dose-response study, L-NAME, at 30 but not at 10 mg/kg impaired the animals' performance, whereas at 60 mg/kg, it induced side-effects." | 1.31 | Molsidomine attenuates N(omega)-nitro-L-argininemethylester-induced deficits in a memory task in the rat. ( Cella, SG; Muller, EE; Pitsikas, N; Rigamonti, AE, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Katsanou, L | 1 |
| Fragkiadaki, E | 1 |
| Kampouris, S | 1 |
| Konstanta, A | 1 |
| Vontzou, A | 1 |
| Pitsikas, N | 5 |
| Schaefer, ML | 1 |
| Wang, M | 1 |
| Perez, PJ | 1 |
| Coca Peralta, W | 1 |
| Xu, J | 1 |
| Johns, RA | 1 |
| Hernández-Melesio, MA | 1 |
| Alcaraz-Zubeldia, M | 1 |
| Jiménez-Capdeville, ME | 1 |
| Martínez-Lazcano, JC | 1 |
| Santoyo-Pérez, ME | 1 |
| Quevedo-Corona, L | 1 |
| Gerónimo-Olvera, C | 1 |
| Sánchez-Mendoza, A | 1 |
| Ríos, C | 1 |
| Pérez-Severiano, F | 1 |
| Boultadakis, A | 1 |
| Liakos, P | 1 |
| Rigamonti, AE | 2 |
| Cella, SG | 2 |
| Muller, EE | 2 |
| Sakellaridis, N | 1 |
7 other studies available for molsidomine and Age-Related Memory Disorders
| Article | Year |
|---|---|
The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat.
Topics: Animals; Clozapine; Cognition; Cognitive Dysfunction; Ketamine; Memory Disorders; Molsidomine; Nitri | 2023 |
Nitric Oxide Donor Prevents Neonatal Isoflurane-induced Impairments in Synaptic Plasticity and Memory.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Disease Models, Animal; Female; Isoflurane; Male | 2019 |
Nitric oxide donor molsidomine promotes retrieval of object recognition memory in a model of cognitive deficit induced by 192 IgG-saporin.
Topics: Acetylcholine; Animals; Antibodies, Monoclonal; Choline O-Acetyltransferase; Cholinergic Neurons; Co | 2019 |
The nitric oxide (NO) donor molsidomine antagonizes scopolamine and L-NAME-induced performance deficits in a spatial memory task in the rat.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory | 2009 |
The nitric oxide-releasing derivative of ferulic acid NCX 2057 antagonized delay-dependent and scopolamine-induced performance deficits in a recognition memory task in the rat.
Topics: Analysis of Variance; Animals; Behavior, Animal; Butanes; Coumaric Acids; Disease Models, Animal; Dr | 2010 |
Molsidomine attenuates N(omega)-nitro-L-argininemethylester-induced deficits in a memory task in the rat.
Topics: Amnesia; Animals; Cognition; Discrimination, Psychological; Enzyme Inhibitors; Male; Memory Disorder | 2002 |
The nitric oxide donor molsidomine antagonizes age-related memory deficits in the rat.
Topics: Age Factors; Aging; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Dose-Respon | 2005 |